Dipharma vs LGM Pharma

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/dipharma/lgmpharma

Category	Dipharma	LGM Pharma
Listed site	cdmo	cdmo
Summary	Global CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.	LGM Pharma offers full-service CDMO support from concept through commercialization, plus API sourcing. It provides analytical method development and stability testing for APIs and drug products, with regulatory strategy support for 505(b)(2) and ANDA filings.
Services	API Synthesis & Manufacturing Process Development CMC Analytical Development Technology Transfer CMC Regulatory Submission Support Quality Control Testing	CMC Analytical Development Stability Testing & Storage CMC Regulatory Submission Support Quality Control Testing
Modalities	Small Molecule	Small Molecule
Indications	Data not yet provided.	Data not yet provided.
Locations	Headquarters, Milan, Lombardy, Italy Commercial Office, United States Commercial Office, China	Data not yet provided.
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.